Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Nonlymphoblastic, Acute”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01159301
What this trial is testing

Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+16 more
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Ended earlyNCT03214666
What this trial is testing

GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies

Who this might be right for
High-risk Myelodysplastic SyndromesAcute Myelogenous LeukemiaSystemic Mastocytosis+1 more
GT Biopharma, Inc. 12
Early research (Phase 1)Looking for participantsNCT05101551
What this trial is testing

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

Who this might be right for
Acute Myeloid Leukemia
Norman J. Lacayo 34
Not applicableNot Yet RecruitingNCT07572695
What this trial is testing

Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML

Who this might be right for
Acute Myeloid LeukemiaRelapsed/Refractory Acute Myeloid LeukemiaAML, Relapsed/Refractory
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Early research (Phase 1)Study completedNCT04372433
What this trial is testing

IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML

Who this might be right for
AML With Monocytic DifferentiationCMML
Immune-Onc Therapeutics 67
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT04938115
What this trial is testing

Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia

Who this might be right for
Leukemia, T Cell
Hebei Senlang Biotechnology Inc., Ltd. 50
Early research (Phase 1)WithdrawnNCT01478074
What this trial is testing

ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Altor BioScience
Early research (Phase 1)Ended earlyNCT00469820
What this trial is testing

Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Not applicableStudy completedNCT00321880
What this trial is testing

Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia

Who this might be right for
FatigueLeukemiaPsychosocial Effects of Cancer and Its Treatment
Wake Forest University Health Sciences 40
Not applicableUnknownNCT03547258
What this trial is testing

Italian Non-Interventional Study of FLT3 Mutated AML Patients

Who this might be right for
AMLFLT3-ITD MutationFLT3-TKD Mutation
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 800
Early research (Phase 1)Study completedNCT03194685
What this trial is testing

Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
AML, Adult
Fujifilm Pharmaceuticals U.S.A., Inc. 97
Testing effectiveness (Phase 2)Study completedNCT00796068
What this trial is testing

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+4 more
Fred Hutchinson Cancer Center 130
Testing effectiveness (Phase 2)Study completedNCT01700413
What this trial is testing

Efficacy and Toxicity of Increasing Doses of Idarubicin, Cytarabine and G-CSF in Acute Myeloid Leukemia

Who this might be right for
Di Novo Acute Myeloid Leukemia
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias 48
Large-scale testing (Phase 3)Looking for participantsNCT07478991
What this trial is testing

Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)

Who this might be right for
Acute Myeloid Leukemia, Adult
PETHEMA Foundation 376
Early research (Phase 1)Ended earlyNCT05654779
What this trial is testing

CLL-1/CD33 Targeted LCAR-AMDR Cells in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 4
Testing effectiveness (Phase 2)Study completedNCT04079296
What this trial is testing

A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome
Astellas Pharma Global Development, Inc. 43
Testing effectiveness (Phase 2)UnknownNCT02310243
What this trial is testing

Study of Palbociclib in MLL-rearranged Acute Leukemias

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
University of Ulm 50
Testing effectiveness (Phase 2)Study completedNCT01188174
What this trial is testing

Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure

Who this might be right for
AML
Nantes University Hospital 26
Not applicableNot Yet RecruitingNCT07563920
What this trial is testing

TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission

Who this might be right for
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 93
Next Page